Advertisement
Australia markets closed

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • AUD/USD

    0.6534
    +0.0011 (+0.17%)
     

  • OIL

    83.62
    +0.05 (+0.06%)
     

  • GOLD

    2,349.20
    +6.70 (+0.29%)
     

  • Bitcoin AUD

    97,734.86
    -1,114.00 (-1.13%)
     

  • CMC Crypto 200

    1,331.56
    -64.98 (-4.49%)
     

  • AUD/EUR

    0.6106
    +0.0033 (+0.54%)
     

  • AUD/NZD

    1.0994
    +0.0036 (+0.33%)
     

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NASDAQ

    17,745.64
    +315.14 (+1.81%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • Dow Jones

    38,272.57
    +186.77 (+0.49%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Investors focused on the Medical space have likely heard of DexCom (DXCM), but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.

DexCom is a member of our Medical group, which includes 887 different companies and currently sits at #1 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. DXCM is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past 90 days, the Zacks Consensus Estimate for DXCM's full-year earnings has moved 49.75% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

ADVERTISEMENT

Our latest available data shows that DXCM has returned about 71.69% since the start of the calendar year. In comparison, Medical companies have returned an average of 3.50%. This means that DexCom is performing better than its sector in terms of year-to-date returns.

Breaking things down more, DXCM is a member of the Medical - Instruments industry, which includes 95 individual companies and currently sits at #84 in the Zacks Industry Rank. This group has gained an average of 14.54% so far this year, so DXCM is performing better in this area.

Investors in the Medical sector will want to keep a close eye on DXCM as it attempts to continue its solid performance.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
DexCom, Inc. (DXCM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research